WebinarsNew
Deep DiveNew
Explore Business Standard
Artificial Intelligence (AI) has the potential to drastically cut the time required to take a drug molecule from the lab to patients, compressing the current five-to-seven-year timeline into just one or two years, Kiran Mazumdar-Shaw of Biocon said on Tuesday. Speaking on the role of AI in life sciences, Shaw, the Executive Chairperson, Biocon Ltd, noted that accelerating this journey from lab to clinic will unlock major opportunities in precision and personalised medicine. "Ultimately the process of drug development doesn't end in the labs. It has to be validated in clinical trials. How do you pick the right patients? How do you conduct these trials in a way that gives you early readouts? "This is all what AI is going to be used for in the future. So today it takes you almost five to seven years to get a molecule from lab all the way to the patients. Can we compress that into a year or two? That is going to be the most fascinating outcome and impact," she said on the first day of t
Killer robots and drones come up for a reckoning this week as government envoys rev up a discussion and could decide whether to launch negotiations toward setting rules for the use of the deadly machines -- or not. Pope Leo XIV, the UN chief and advocacy groups cast the issue as an existential debate: Whether robots can be allowed to kill and whether humans must maintain some control of and accountability for the use of lethal autonomous weapon systems. Activists say armed drones that can independently strike targets have already been deployed in some select instances in conflict zones like Ukraine and the Middle East, but widespread rollout hasn't happened. Scary would-be scenarios, like armed drones flying amok and gunning down civilians with pinpoint precision, have peppered years of discussions about killer robots. But those talks haven't produced any international restrictions. The United States and Russia, longtime rivals, want to limit any curbs on their abilities to develop
IBM spends about USD 3 billion annually in India and plans to invest USD 10 billion globally in quantum computing over the next five years, Chairman and Chief Executive Arvind Krishna said, underlining the technology major's long-term commitment to the country even as he flagged significant disruption to employment from artificial intelligence. AI could displace 10-20 per cent of jobs over the next decade, with the business process outsourcing (BPO) industry likely to face some of the biggest reductions in employment, Krishna said, arguing that businesses and governments would need to prepare workers for changes in the nature of work. "Whenever these happen, there is some level of displacement. I think we should face up to that," he said during an interaction with journalists. The impact, however, would unfold over a decade rather than within a year, he said, adding that society needed to consider how to help workers adapt to the transition. "If I was to tell you the part, I think